Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RATH MED BLOMSTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.6% 3.6%   Bankruptcy risk   3.2% 3.1% 5.1% 5.5% 5.7% 5.7% 15.0% 14.7%   Credit score (0-100)   57 58 43 40 39 39 14 14   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 5,181 2,272 1,808 1,808 1,808   Gross profit   2,083 1,845 0.0 1,922 1,153 824 0.0 0.0   EBITDA   98.2 32.5 116 90.0 22.0 -78.9 0.0 0.0   EBIT   58.6 16.8 14.1 28.6 12.0 -78.9 0.0 0.0   Pre-tax profit (PTP)   48.6 12.1 10.7 24.5 10.0 -89.1 0.0 0.0   Net earnings   36.7 8.7 7.5 19.1 7.7 -69.6 0.0 0.0   Pre-tax profit without non-rec. items   48.6 12.1 10.7 24.5 10.0 -89.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   115 252 150 88.7 78.7 87.2 0.0 0.0   Shareholders equity total   436 444 452 471 479 409 284 284   Interest-bearing liabilities   92.0 395 25.3 311 12.3 308 0.0 0.0   Balance sheet total (assets)   913 1,213 1,390 1,197 787 938 284 284   Net Debt   29.7 367 -200 307 -19.3 245 -284 -284     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 5,181 2,272 1,808 1,808 1,808   Net sales growth   0.0% 0.0% 0.0% 0.0% -56.2% -20.4% 0.0% 0.0%   Gross profit   2,083 1,845 0.0 1,922 1,153 824 0.0 0.0   Gross profit growth   11.2% -11.4% -100.0% 0.0% -40.0% -28.5% -100.0% 0.0%   Employees   0 0 0 0 0 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   913 1,213 1,390 1,197 787 938 284 284   Balance sheet change%   -14.5% 32.9% 14.6% -13.8% -34.3% 19.2% -69.7% 0.0%   Added value   98.2 32.5 115.6 90.0 73.5 -78.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 1.7% 3.2% -4.4% 0.0% 0.0%   Investments   16 121 -203 -123 -20 8 -87 0   Net sales trend   0.0 0.0 0.0 0.0 -1.0 -2.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 1.7% 1.0% -4.4% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.6% 0.5% -4.4% 0.0% 0.0%   EBIT to gross profit (%)   2.8% 0.9% 0.0% 1.5% 1.0% -9.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.4% 0.3% -3.8% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 1.6% 0.8% -3.8% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.5% 0.4% -4.9% 0.0% 0.0%   ROA %   5.9% 1.6% 1.1% 2.2% 1.2% -9.2% 0.0% 0.0%   ROI %   9.4% 2.5% 2.1% 4.5% 1.9% -13.1% 0.0% 0.0%   ROE %   8.6% 2.0% 1.7% 4.1% 1.6% -15.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   47.7% 36.7% 32.5% 39.3% 60.8% 43.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 14.0% 13.6% 29.3% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 13.9% 12.2% 25.8% -15.7% -15.7%   Net int. bear. debt to EBITDA, %   30.2% 1,131.3% -173.1% 341.5% -87.4% -310.2% 0.0% 0.0%   Gearing %   21.1% 88.9% 5.6% 66.1% 2.6% 75.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.2% 1.9% 1.6% 2.4% 1.3% 6.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.0   Current Ratio   1.5 1.1 1.2 1.3 2.1 1.5 0.0 0.0   Cash and cash equivalent   62.3 27.7 225.4 4.0 31.6 63.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 28.8 12.8 33.9 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 10.4 18.7 10.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 18.7% 28.0% 43.1% 15.7% 15.7%   Net working capital   238.5 109.3 218.3 242.8 327.9 249.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 4.7% 14.4% 13.8% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 603 0 0   Added value / employee   0 0 0 0 0 -26 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -26 0 0   EBIT / employee   0 0 0 0 0 -26 0 0   Net earnings / employee   0 0 0 0 0 -23 0 0